Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JAK2 Expression in Androgenic Alopecia and Modulation by Minoxidil
NCT07563036Recruiting
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Feb 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of minoxidil in androgenetic alopecia (AGA), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Baseline Difference in Tissue JAK2 Protein Levels Between Balding and Non-Balding Scalp at 0 weeks. Started Feb 2026; status: recruiting.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT07563036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07563036.